Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-10-017451)

Filing Details

Accession Number:: 0001179110-10-017451
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-12-13 19:06:00
Reporting Period:: 2010-12-10

Filing Date:: 2010-12-13
Accepted Time:: 2010-12-13 19:06:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1080014	Theravance Inc	THRX	Pharmaceutical Preparations (2834)	943265960

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1217420	D William Young	Theravance, Inc. 901 Gateway Boulevard South San Francisco CA 94080		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-12-10	10,754	$8.53	28,754	No	4	M	Direct
Common Stock	Disposition	2010-12-10	5,377	$26.64	23,377	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2010-12-10	10,754	$0.00	10,754	$8.53

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
21,504		2011-04-07	No	4	M	Direct

Footnotes

This transaction was executed in multiple trades at prices ranging from $26.36 to $26.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Immediately exercisable.